4//SEC Filing
Vanston David Cecil 4
Accession 0001078782-19-000128
CIK 0000093314other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 4:30 PM ET
Size
5.4 KB
Accession
0001078782-19-000128
Insider Transaction Report
Form 4
VOLITIONRX LTDVNRX
Vanston David Cecil
Chief Financial Officer
Transactions
- Award
Stock Options (Right to Buy)
2019-02-11+50,000→ 50,000 totalExercise: $3.25From: 2020-02-11Exp: 2025-02-11→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]A total of 50,000 Options were granted on February 11, 2019 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant.
Documents
Issuer
VOLITIONRX LTD
CIK 0000093314
Entity typeother
Related Parties
1- filerCIK 0001703012
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 4:30 PM ET
- Size
- 5.4 KB